GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
by Elana GotkineFor patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according t
Updated on: November 21,2024
0

GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
by Elana GotkineFor patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE), according t
Updated on:November 21,2024
0
